- CLDX has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $24.9 million.
- CLDX has traded 54,878 shares today.
- CLDX is up 4.2% today.
- CLDX was down 5.4% yesterday.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in CLDX with the Ticky from Trade-Ideas. See the FREE profile for CLDX NOW at Trade-Ideas More details on CLDX: Celldex Therapeutics, Inc., a biopharmaceutical company, develops, manufactures, and commercializes novel therapeutics for human health care in the United States. Currently there are 8 analysts that rate Celldex Therapeutics a buy, no analysts rate it a sell, and none rate it a hold. The average volume for Celldex Therapeutics has been 1.7 million shares per day over the past 30 days. Celldex has a market cap of $2.5 billion and is part of the health care sector and drugs industry. The stock has a beta of 2.33 and a short float of 19.1% with 16.03 days to cover. Shares are up 37.1% year-to-date as of the close of trading on Monday. EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.